Journal of Manipulative and Physiological Therapeutics
Volume 28, Issue 3 , Pages 179-186 , March 2005

Insomnia: Does Chiropractic Help?

  • Jennifer R. Jamison, PhD, EdD

      Affiliations

    • Professor of Primary Care, School of Chiropractic, Division of Health Sciences, Murdoch University
    • Corresponding Author InformationSubmit requests for reprints to: Jennifer R. Jamison, PhD, EdD, Professor of Primary Care School of Chiropractic, Division of Health Sciences, Murdoch University, GPO Box S1400, Perth, Western Australia 6849, Australia.

Received 14 April 2004 ,Revised 30 July 2004

References 

  1. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111
  2. Olson LG. A community survey of insomnia in Newcastle. Aust N Z J Public Health. 1996;20:655–657
  3. Martikainen K, Partinen M, Hasan J, Laippala P, Urponen H, Vuori I. The impact of somatic health problems on insomnia in middle age. Sleep Med. 2003;4:201–206
  4. Ohayon MM, Partinen M. Insomnia and global sleep dissatisfaction in Finland. J Sleep Res. 2002;11:339–346
  5. Lobbezoo F, Visscher CM, Naeije M. Impaired health status, sleep disorders, and pain in the craniomandibular and cervical spinal regions. Eur J Pain. 2004;8:23–30
  6. Wilson KG, Eriksson MY, D'Eon JL, Mikail SF, Emery PC. Major depression and insomnia in chronic pain. Clin J Pain. 2002;18:77–83
  7. Sayar K, Arikan M, Yontem T. Sleep quality in chronic pain patients. Can J Psychiatry. 2002;47:844–848
  8. Moldofsky H. Sleep and pain. Sleep Med Rev. 2001;5:385–396
  9. Mant A, de Burgh S, Mattick RP, Donnelly N, Hall W. Insomnia in general practice. Results from NSW General Practice Survey 1991-1992. Aust Fam Physician. 1996;(Suppl. 1):S15–S18
  10. Ohayon MM, Caulet M, Arbus L, Billard M, Coquerel A, Guieu JD, et al. Are prescribed medications effective in the treatment of insomnia complaints?. J Psychosom Res. 1999;47:359–368
  11. Krystal AD. The changing perspective on chronic insomnia management. J Clin Psychiatry. 2004;65(Suppl. 8):20–25
  12. Regestein QR. Specific effects of sedative/hypnotic drugs in the treatment of incapacitating chronic insomnia. Am J Med. 1987;83:909–916
  13. Hirst A, Sloan R. Benzodiazepines and related drugs for insomnia in palliative care. Cochrane Database Syst Rev. 2002;(4):CD003346
  14. Long L, Huntley A, Ernst E. Which complementary and alternative therapies benefit which conditions? A survey of the opinions of 223 professional organizations. Complement Ther Med. 2001;9:178–185
  15. Vernon H. Qualitative review of studies of manipulation-induced hypoalgesia. J Manipulative Physiol Ther. 2000;23:134–138
  16. Abenhaim L, Bergeron AM. Twenty years of randomized clinical trials of manipulative therapy for back pain: a review. Clin Invest Med. 1992;15:527–535
  17. Koes BW, Assendelft WJ, van der Heijden GJ, Bouter LM. Spinal manipulation for low back pain. An updated systematic review of randomized clinical trials. Spine. 1996;21:2860–2871
  18. Ernst E. Manual therapies for pain control: Chiropractic and massage. Clin J Pain. 2004;20:8–12
  19. UK Back pain exercise and manipulation (UK BEAM) trial team . UK Back pain Exercise And Manipulation (UK BEAM) trial-national randomized trial of physical treatments for back pain in primary care: objectives, design and interventions. BMC Health Serv Res. 2003;3:16
  20. Semmes CE. Nonmedical illness behavior: a model of patients who seek alternatives to allopathic medicine. J Manipulative Physiol Ther. 1990;13:427–436
  21. Tursky B. The 55% analgesic effect: real or artefact?. In:  White L,  Tursky B,  Schwartz GE editor. Placebo: theory, research and mechanisms. New York: Guilford Press; 1985;p. 229–234
  22. Blackwell B, Bloomfield SS, Buncher CR. Demonstration to medical students of placebo responses and non-drug factors. Lancet. 1972;1:1279–1282
  23. Borkovec TD. Placebo: defining the unknown. In: White L, Tursky B, Schwartz GE, editors. Placebo: theory, research and mechanisms. New York: Guilford Press; 1985. p. 59,62.
  24. Tomatis L. Environmental cancer risk factors. Acta Oncologica. 1988;27:465–472
  25. Ayanian JZ, Cleary PD. Perceived risks of heart disease and cancer among cigarette smokers. JAMA. 1999;281:1019–1021
  26. Roth T, Hajak G, Ustun TB. Consensus for the pharmacological management of insomnia in the new millennium. Int J Clin Pract. 2001;55:42–52
  27. Jamison JR. Maintaining health in primary care. In: Edinburgh: Churchill Livingstone; 2001;p. 135–146
  28. Eddy M, Walbroehl GS. Insomnia. Am Fam Physician 1999;59:1911-6,1918.
  29. Backhaus J, Hohagen F, Voderholzer U, Riemann D. Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia. Eur Arch Psychiatry Clin Neurosci. 2001;251:35–41
  30. Attele AS, Xie J-T, Yuan C-S. Treatment of insomnia: an alternative approach. Altern Med Rev. 2000;5:249–259
  31. Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry. 2000;33:47–53
  32. Kuhlmann J, Berger W, Podzuweit H, Schmidt U. The influence of valerian treatment on “reaction time, alertness and concentration” in volunteers. Pharmacopsychiatry. 1999;32:235–241
  33. Miller LG, Murrey WJ. Herbal medications, nutraceuticals, and anxiety and depression. In: Herbal medicine: a clinician's guide. New York: Pharmaceutical Products Press; 1998;p. 211–212
  34. Wing YK. Herbal treatment of insomnia. Hong Kong Med J. 2001;7:392–402

PII: S0161-4754(05)00057-6

doi: 10.1016/j.jmpt.2005.02.013

Journal of Manipulative and Physiological Therapeutics
Volume 28, Issue 3 , Pages 179-186 , March 2005

Article Tools

* Image Usage & Resolution